NCT01613443View on ClinicalTrials.gov

Ex-vivo Effect of New Oral Anticoagulants on Point-of-care Devices

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

August 31, 2013

Conditions

Effect of NOAC on POCT

All Listed Sponsors

lead

Cardioangiologisches Centrum Bethanien

OTHER

NCT01613443 - Ex-vivo Effect of New Oral Anticoagulants on Point-of-care Devices | Biotech Hunter | Biotech Hunter